Arylcyclohexylamine

An Arylcyclohexylamine is a chemical class that consists of a compound with a cyclohexylamine unit bonded to an aryl moiety.

• AKA: Arylcyclohexamine, Arylcyclohexanamine.
• Context:
  • It can (typically) contain a cyclohexane ring as its core molecular scaffold.
  • It can (typically) bear an amine group attached to the cyclohexane ring.
  • It can (typically) feature an aryl group substituent, such as a phenyl group or a thiophene group.
  • It can (typically) act as a dissociative anesthetic through its pharmacological action.
  • It can (typically) function as an NMDA receptor antagonist via NMDA receptor channel blockade.
  • It can (often) produce dissociative effects in the central nervous system.
  • It can (often) exhibit analgesic effects useful for pain management.
  • It can (often) exhibit hallucinogenic effects at higher doses.
  • It can (often) exhibit stimulant effects depending on its receptor affinity.
  • It can (often) interact with the dopamine transporter to modulate dopamine reuptake.
  • It can (often) interact with the sigma receptor and other monoamine transporters.
  • It can (often) be synthesized through a Bruylants reaction or related organic synthesis route.
  • It can (often) be marketed as a research chemical outside regulated medical use.
  • It can (often) be subject to drug scheduling under controlled substance legislation.
  • It can (often) form salts such as the hydrochloride salt for pharmaceutical formulation.
  • It can be studied for its structure-activity relationship across chemical derivatives.
  • It can be administered via oral route, intravenous route, or insufflation route.
  • It can exist as a chiral compound with distinct enantiomers of differing potency.
  • It can range from being a Clinical Anesthetic Agent to being a Recreational Designer Drug, depending on its legal status.
  • It can range from being a Short-Acting Dissociative to being a Long-Acting Dissociative, depending on its pharmacokinetic profile.
  • It can range from being a Low-Potency Analog to being a High-Potency Analog, depending on its receptor binding affinity.
  • …
• Example(s):
  • Clinical Arylcyclohexylamines, such as:
    • Ketamine, a dissociative anesthetic used in veterinary medicine and human medicine.
    • Phencyclidine (PCP), an early anesthetic agent later withdrawn from clinical use.
    • Tiletamine, a veterinary anesthetic often combined with zolazepam.
  • Designer Arylcyclohexylamines, such as:
    • Methoxetamine (MXE), a research chemical and ketamine analog.
    • Deschloroketamine (DCK), a structural analog of ketamine.
    • Eticyclidine (PCE), a phencyclidine analog.
    • Rolicyclidine (PCPy), a phencyclidine analog.
  • Experimental Arylcyclohexylamines, such as:
    • Gacyclidine, investigated as a neuroprotective agent.
    • Dieticyclidine, studied for its NMDA receptor antagonist activity.
  • …
• Counter-Example(s):
  • Barbiturates, which act as GABA receptor modulators rather than NMDA receptor antagonists.
  • Benzodiazepines, which lack the dissociative effect profile and target GABA-A receptors.
  • Opioids, which produce analgesic effects through opioid receptors rather than NMDA receptor blockade.
  • Cyclohexylamine itself, which lacks the aryl moiety and psychoactive properties.
  • …
• See: Chiral Compound, Experimental Drug, Chemical Class, Pharmaceutical Drug, Designer Drug, NMDA Receptor Antagonist, Dissociative Anesthetic, Ketamine, Phencyclidine, Research Chemical, Controlled Substance.

---

References

2023

• (Wikipedia, 2023) ⇒ https://en.wikipedia.org/wiki/arylcyclohexylamine Retrieved:2023-8-2.
  • Arylcyclohexylamines, also known as arylcyclohexamines or arylcyclohexanamines, are a chemical class of pharmaceutical, designer, and experimental drugs.

---